Signal Peptide Database

Signal Peptide Database - Viruses

Entry Details

3024

Source Database

UniProtKB/Swiss-Prot

UniProtKB/Swiss-Prot Accession Number

Q7T6X2 (Created: 2006-10-17 Updated: 2009-01-20)

UniProtKB/Swiss-Prot Entry Name

YR826_MIMIV

Protein Name

Putative serine/threonine-protein kinase/receptor R826

Gene

MIMI_R826

Organism Scientific

Acanthamoeba polyphaga mimivirus

Organism Common

APMV

Lineage

Viruses
  dsDNA viruses, no RNA stage
    Mimiviridae
      Mimivirus

Protein Length [aa]

1657

Protein Mass [Da]

186740

Features

TypeDescriptionStatusStartEnd
signal peptide      potential   1   23
chain   Putative serine/threonine-protein kinase/receptor R826      24   1657
transmembrane region      potential   742   762
domain   Protein kinase 1      786   1049
domain   Guanylate cyclase      1134   1277
domain   Protein kinase 2      1399   1651
glycosylation site   N-linked (GlcNAc...)   potential   153   153
glycosylation site   N-linked (GlcNAc...)   potential   178   178
glycosylation site   N-linked (GlcNAc...)   potential   238   238
glycosylation site   N-linked (GlcNAc...)   potential   255   255
glycosylation site   N-linked (GlcNAc...)   potential   352   352
glycosylation site   N-linked (GlcNAc...)   potential   454   454
glycosylation site   N-linked (GlcNAc...)   potential   476   476
glycosylation site   N-linked (GlcNAc...)   potential   494   494
glycosylation site   N-linked (GlcNAc...)   potential   596   596
active site   Proton acceptor   by similarity   909   909
active site   Proton acceptor   by similarity   1522   1522
binding site   ATP   by similarity   813   813
binding site   ATP   by similarity   1426   1426
compositionally biased region   Poly-Ser      1058   1065
nucleotide phosphate-binding region   ATP   by similarity   792   800
nucleotide phosphate-binding region   ATP   by similarity   1405   1413

SP Length

----+----1----+----2----+----3----+----4----+----5

Signal Peptide

MRLNSQIVFCIVVVISCLSMIEC

Sequence

MRLNSQIVFCIVVVISCLSMIECKMGSRIYCSGSLSSVELFSQYISNYAL
RNDDVTIIYAGMSVDEINADVYIADCSAYDRAIPQIYMISYGLIQFPIVG
QAIVIIYNVPGLSSHNMIIDRETLGRIWTGNIRKWNDIQIQNLNPDIASQ
LPNETITLGYNDAYYLSISEIMQLALRNFSEEFANAHTIAGGKFGNMIPA
KQGYAIDAGEASESRIDWVKNTPFSLSFADFATVYPRNVSYMHMYNKAGK
LVEPNITTVQSAMADFKEIYTTNDFTIDIFDASGENSWPISWVNYISMTS
TFQQADCIRTKELLDFIAWFYMNNEIAEIIKEYQYYPLDNTIKKIAIDNM
YNVTCNGKVSQEHQYLIAFGSPLSIMASWPNTWASSMTTVKYYASLSDQA
IELQKTFSGDFGITIKDFDKNKYLSSTMEDIGVSHLAAFNIVPAYNIPEF
IGLNETLVLNYETIVDIYLGLVTNWNDSSIRNSNNPYINSLLPNKTITVV
VQKVESDVNELFTNFLSCKSDKFNNAIGPTNLPEFDFVSNNVVYTEDVYG
VGNTLVSTDYSFAFWPEPGIRLLSHMAIVQAASIQTSTGTIIKPTNETLS
KAVDNKINSINRRDIEDGSWPFIAMMSLVYHQKTMQSFSKASALADFIYW
TQFDDTAASIADTQGYYVASIHPTILRENLELLQSFTFEDRTVSKVANCI
FEGTICYNKGTCNNNVCLCNIDREGQFCELEKTQSDTNIVTIILAVVIPI
AFIIVCIICILVVALIFSLRFRKGISDDWEIDFHELELGEQLGTGAFGEV
HKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRVMTTLRHPNVVLFMAA
STKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQASKGMHFL
HSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQ
WTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVI
RDNYRPVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMG
DSGMTGMSSSSSNSSKFDYNSFGKVQQFAINRTDPDGIVQNSYNRTDSYD
LGSNNSHSSITSDTNKSNKYLRQTNIQHPTGEVVVVFTDIISAAQLWEFD
ASEMKNATILYNKLVRSICNECGGYESLISKERNSGEGSFCLIFSDVQNA
ITFCEELQKQLVGVNWSPKLLEHPITAIEKDINGTIIYAGLRVRIGLHFG
STKINYDPISRKYEYIGPTVTTAAAVTTITHGGQIIMTEDVANKLSTENS
NKPVCLGRVDIDGIPDSLVLYEYVISALIGRFFGGVTRKNASFVSNETST
DYDDMDTDNSTFSARVPHQAYQYHAAIENNERYLTSAGLCSWVINYDEIK
MGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKK
LHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKI
LVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEEN
AIMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANF
MKITMDILEDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVLAK
FCPDISV

Original

----+----1----+----2----+----3----+----4----+----5

Hydropathies

Signal Peptide Website